LOXL2 and pachyonychia congenita: Based on the results of the multivariate analysis, older age (≥65 years), gender (male), tumor location (head), portal vein invasion, perineural invasion, UICC stage, mesenchymal EMT status and high LOXL2 expression were independent predictive factors for OS in patients with PC (Table 4).